These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 4661188

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Value of the spironolactone test in the diagnosis of primary hyperaldosteronism.
    Jessurun RF, Struyvenberg A, Dorhout Mees EJ.
    Neth J Med; 1979; 22(1):23-6. PubMed ID: 418941
    [No Abstract] [Full Text] [Related]

  • 4. Non-tumorous "primary" aldosteronism. I. Type relieved by glucocorticoid (glucocorticoid-remediable aldosteronism).
    Salti IS, Stiefel M, Ruse JL, Laidlaw JC.
    Can Med Assoc J; 1969 Jul 12; 101(1):1-10. PubMed ID: 5793351
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Spironolactone in essential hypertension associated with abnormal aldosterone regulation and in Conn's syndrome (author's transl)].
    Wambach G, Helber A, Bönner G, Hummerich W, Meurer KA, Kaufmann W.
    Dtsch Med Wochenschr; 1980 May 02; 105(18):647-51. PubMed ID: 7371530
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Relationship between sweat, sodium and potassium excretion and the renin-angiotensin-aldosterone system in hypertension].
    Rosset G.
    Schweiz Med Wochenschr; 1973 Mar 24; 103(12):439-48. PubMed ID: 4697590
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of add-on aldosterone receptor blocker in uncontrolled hypertension.
    Sharabi Y, Adler E, Shamis A, Nussinovitch N, Markovitz A, Grossman E.
    Am J Hypertens; 2006 Jul 24; 19(7):750-5. PubMed ID: 16814132
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hyperaldosteronism in hypertensive congenital adrenal hyperplasia.
    Lim NY, Mimica N, Dingman JF.
    J Clin Endocrinol Metab; 1969 Dec 24; 29(12):1564-8. PubMed ID: 4310498
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.